This episode of TDR Cannabis in Five features Shadd Dales reviewing new research comparing cannabis and prescription painkillers for chronic pain. Presented in third-person, the segment highlights findings from the University of Pittsburgh, BMJ Open, JAMA, and national data on how patients are managing pain today.Shadd covers the Pittsburgh study showing that medical cannabis patients reported slightly higher improvement rates than those taking prescription pain medications. The episode also notes that patients using both cannabis and opioids were more likely to reduce their opioid use over time, a meaningful trend given ongoing concerns about dependency and overdose risk.The segment also summarizes JAMA’s findings showing that nearly one in three chronic pain patients now use cannabis, with many turning to it as an alternative or supplement to opioids. Meta-analyses from BMJ Open further support cannabis as a comparable option with fewer long-term risks.Overall, the episode outlines the numbers, the real-world patient impact, and how this evidence is shaping the conversation around chronic pain treatment.#MedicalCannabis #ChronicPain #OpioidCrisis #PainManagement #CannabisResearch #CannabisNews #WeedHealth #TDRMedia #MedicalMarijuana #healthnews Want to see more Cannabis Reform videos?   • GOP Leader Suggests Trump May Move Toward ...     • Virginia Moves Toward Cannabis Retail Sale...     • California’s Cannabis Program Must Change ...     • Supreme Court Takes a Look at Cannabis | T...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te..

This episode of TDR Cannabis in Five features Shadd Dales reviewing new comments from Rep. Guy Reschenthaler, one of the highest-ranking Republicans in the U.S. House. In remarks reported by Marijuana Moment, he said he is “cautiously optimistic” that Donald Trump would move to reschedule marijuana if elected. This summary is presented in third-person and focuses on the substance of the signal.Shadd explains why Reschenthaler’s position matters—he’s the Chief Deputy Whip, not a fringe voice. His comments reflect a shift within parts of the GOP, especially around medical access, veterans’ treatment, and opioid alternatives. Reschenthaler highlighted how cannabis could help veterans manage chronic pain and traumatic brain injuries without relying on opioids.The episode also breaks down what rescheduling would actually change: easier research pathways, federal acknowledgment of medical use, and potential reform momentum around issues like banking access and tax penalties under 280E. Reschenthaler has supported related legislation in the past, adding weight to his comments.Overall, the episode reviews what was said, why it matters politically, and what rescheduling would mean for medical users, veterans, cannabis operators, and investors.#CannabisRescheduling #GuyReschenthaler #Trump2026 #CannabisNews #WeedPolitics #VeteransCare #OpioidCrisis #TDRMedia #MSOS #CannabisPolicyWant to see more Cannabis Reform videos?   • Virginia Moves Toward Cannabis Retail Sale...     • California’s Cannabis Program Must Change ...     • Supreme Court Takes a Look at Cannabis | T...     • Inside the HHS Rescheduling Report | TDR C...     • Three Months That Made Cannabis Impossible...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

This episode of TDR Cannabis in Five features Shadd Dales covering the latest cannabis update out of Virginia, where lawmakers are preparing to introduce a bill that would finally launch regulated cannabis sales in 2026. Presented in third-person, the segment explains how this development fits into the state’s complicated history with legalization.Shadd outlines how Virginia legalized possession years ago but never created a retail system, leaving residents with legal possession but no legal access. This gap has fueled the illicit market and confused consumers. The upcoming bill aims to resolve this with rules around licensing, taxes, equity, and consumer protections.Plus we highlight Virginia’s political landscape. With Abigail Spanberger recently elected governor, her administration will ultimately oversee the rollout. Lawmakers and industry players are watching closely to see how her leadership shapes the regulatory structure.Overall, the segment covers what the bill is expected to include, why the timing matters, and how Virginia’s next steps could impact both local businesses and broader national cannabis momentum heading into 2026.#VirginiaCannabis #VACannabis #CannabisNews #Legalization2026 #WeedPolitics #CannabisMarket #MSOS #TDRMedia #SouthernCannabis #cannabisreform Want to see more Cannabis Reform videos?   • California’s Cannabis Program Must Change ...     • Supreme Court Takes a Look at Cannabis | T...     • Inside the HHS Rescheduling Report | TDR C...     • Three Months That Made Cannabis Impossible...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

This episode of TDR Cannabis in Five features Shadd Dales breaking down a Marijuana Moment op-ed by Hirsh Jain of Ananda Strategy, focusing on the problems inside California’s cannabis program and what the state’s new regulator must address.The episode outlines Jain’s central argument: California, despite being the world’s largest cannabis market, has built a system that often hurts legal operators while enabling the illicit market. High taxes, heavy fees, slow licensing, weak enforcement, and widespread municipal bans have pushed many consumers back to illegal sellers.We review the key fixes Jain says are necessary, including lower taxes, streamlined licensing, broader retail access, and smarter enforcement strategies. The video also explains why this matters nationally: if California can’t execute a functioning legal market, it creates hesitation for institutional investors and sends the wrong message to other states working toward reform.Overall, the episode lays out what’s wrong, what needs to change, and how California’s next regulatory move could influence the entire U.S. cannabis landscape.#CaliforniaCannabis #CannabisNews #WeedPolitics #CannabisReform #HirshJain #CannabisMarket #WeedStocks #MSOS #TDRMedia #CannabisRegulationWant to see more Cannabis Reform videos?   • Supreme Court Takes a Look at Cannabis | T...     • Inside the HHS Rescheduling Report | TDR C...     • Three Months That Made Cannabis Impossible...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

This episode of TDR Cannabis in Five features Shadd Dales breaking down the Tilray (NASDAQ: TLRY) news that had investors talking over Thanksgiving weekend. This description reflects the episode in third-person and keeps the tone neutral and factual.The video covers Tilray’s announcement of a 1-for-10 reverse stock split, released late Wednesday heading into the long weekend. By Friday morning, the stock was down nearly 20%. We review why reverse splits are usually seen as a defensive move and how this one appears more than just Nasdaq’s $1 share-price requirement, it’s about attracting institutional investors long term. Shadd also discusses the company’s positioning, CEO Irwin Simon’s comments about “intrinsic value,” and why the market hasn’t responded positively. With shares down more than 45% year-to-date, the episode lays out the difference between messaging and market sentiment.#Tilray #TLRY #CannabisStocks #WeedStocks #CannabisNews #MarketUpdate #ReverseSplit #InvestingNews #MSOS #CannabisReformWant to see more Cannabis Reform videos?   • Supreme Court Takes a Look at Cannabis | T...     • Inside the HHS Rescheduling Report | TDR C...     • Three Months That Made Cannabis Impossible...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

Trade To Black Podcast is back with another jam-packed episode as hosts Anthony Varrell and Shadd Dales are joined by special guest Michael Bronstein, President of ATACH (American Trade Association for Cannabis and Hemp), to break down three of the biggest storylines shaking up the cannabis industry: Tilray’s reverse split, the new sheriff in charge of California cannabis, and the U.S. Supreme Court’s pending review of key cannabis cases.We start with Tilray Brands’ (TLRY) latest reverse stock split—why it happened, what it means for share structure, exchange compliance, ETF inclusion, and broader sentiment toward cannabis equities. Anthony and Shadd walk through how this move fits into the consolidation trend across the sector, while Michael adds the policy and institutional lens on how capital markets are treating U.S. vs. Canadian operators.Then we head to California, where there’s effectively a new sheriff running the cannabis industry with a tougher posture on enforcement, illicit markets, and regulatory compliance. Is this the turning point California’s legal market needs? We unpack the impact on operators, taxes, pricing, and whether real reform can finally level the playing field against the legacy market.Finally, Michael Bronstein helps decode the Supreme Court’s upcoming look at several cannabis-related cases—from federal preemption and 280E implications to interstate commerce and states’ rights. Could these cases open the door to broader reform, or tighten federal constraints on the industry?Whether you’re a cannabis investor, operator, lawyer, or policy nerd tracking MSOS, TLRY, CURLF, GTII, TRUL, and VRNOF, this episode delivers high-level insight from one of the industry’s top policy voices.

High Tide (NASDAQ: HITI, TSXV: HITI) just made one of the boldest moves the cannabis retail sector has seen in years. In this episode of TDR Cannabis in Five, host Shadd Dales breaks down why the company’s first-ever Canna Cabana store in Berlin isn’t just a big announcement — it’s a global signal.This marks the first time a publicly traded North American cannabis retailer has opened a physical store in Europe’s largest cannabis market, and they didn’t choose a low-traffic location. The Berlin storefront sits in the heart of Berlin-Mitte, steps from Alexanderplatz, giving High Tide (NASDAQ: HITI, TSXV: HITI) instant visibility in one of Europe’s most dynamic cities.Shadd explains how this strategy mirrors High Tide’s early Canadian playbook — building loyalty through accessories and lifestyle retail long before cannabis regulations fully open up. With Germany importing record volumes of medical cannabis and moving toward broader liberalization, the timing is calculated, not reactive.The episode also explores how this Berlin launch fits into High Tide’s European strategy following its acquisition of Remexian Pharma GmbH. Medical distribution, e-commerce, and bricks-and-mortar retail now operate under one ecosystem.The takeaway: this won’t reshape Europe overnight, but it’s a strong first step from a company clearly thinking beyond Canada. High Tide (NASDAQ: HITI, TSXV: HITI) is making a long-term bet — and the Berlin opening is just the start.#HighTide #HITI #CannaCabana #CannabisRetail #TDRCannabisInFive #ShaddDales #GermanyCannabis #BerlinRetail #CannabisExpansion #MorganAndMorganWant to see more Cannabis Reform videos?   • Supreme Court Takes a Look at Cannabis | T...     • Inside the HHS Rescheduling Report | TDR C...     • Three Months That Made Cannabis Impossible...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

What were the five moments that actually defined cannabis so far here in 2025?In this episode of TDR Cannabis in Five, presented by Dutchie, host Shadd Dales breaks down the political, financial, and cultural shifts that have shaped the industry this year — and the trends that are already setting up the road to 2026.The first major inflection point came on August 11, when President Trump publicly confirmed his administration was actively reviewing cannabis rescheduling. That single remark immediately moved markets, pushed operators to rethink strategy, and shifted federal reform from speculation to a near-term conversation.The second moment was the most dramatic: a nationwide ban on intoxicating hemp-derived THC products — Delta-8, Delta-10, THCA flower, and anything with detectable THC — wiping out roughly $28 billion in sales overnight. Industrial hemp remains legal, but the consumer intoxicant market was eliminated.Next was the corporate collapse of Ayr Wellness (CSE: AYR.A, OTCQX: AYRWF). After months of lender-directed restructuring, the company formally entered Canada’s CCAA creditor-protection process on November 17, marking one of the largest cannabis restructurings North America has seen.Fourth, Village Farms (NASDAQ: VFF) shifted its entire corporate identity. Following the privatization of its produce business and a roughly $40 million cash boost, Village Farms effectively repositioned itself as a cannabis-first operator with global momentum.Finally, President Trump’s late-September Truth Social video praising cannabinoids — especially CBD — pushed cannabis deeper into political mainstream messaging, particularly among older voters.These five moments didn’t just make news — they shaped cannabis so far in 2025.#CannabisNews #CannabisReform #HempBan #AyrWellness #VillageFarms #CBD #Rescheduling #CannabisStocks #Trump #TrumpAdministration #TruthSocial Want to see more Cannabis Reform videos?   • Supreme Court Takes a Look at Cannabis | T...     • Inside the HHS Rescheduling Report | TDR C...     • Three Months That Made Cannabis Impossible...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

Earlier this week, Marijuana Moment reported that the U.S. Supreme Court will privately meet on December 12 to decide whether to take on a case that could reshape federal cannabis law. State-legal cannabis companies are petitioning the Court to rule that the Controlled Substances Act violates the Constitution’s Commerce Clause when applied to activities taking place entirely within legal states.In this episode of TDR Cannabis in Five, host Shadd Dales breaks down what this closed-door Supreme Court meeting actually means — procedurally, legally, and for the business side of the industry. Backed by powerhouse firm Boies Schiller Flexner LLP, the petition challenges decades of federal precedent. The Department of Justice choosing not to file a brief adds another twist.The conversation also covers what could unfold depending on the Court’s decision: whether federal prohibition weakens, whether interstate commerce becomes possible, and how institutional investors might re-evaluate the sector if the constitutional ground shifts.The takeaway is simple: it is a real legal moment worth paying attention to. Whether the Court takes the case or not, the implications matter for policy watchers, operators, and investors who follow long-term federal signals closely.#SupremeCourt #CannabisLaw #FederalCannabis #TDRCannabisInFive #ShaddDales #CannabisPolicy #CannabisReform #MarijuanaMoment #MorganAndMorgan #CannabisNewsWant to see more Cannabis Reform videos?   • Inside the HHS Rescheduling Report | TDR C...     • Three Months That Made Cannabis Impossible...     • Three Months That Made Cannabis Impossible...     • High Tide Executive Warns the Canadian Can...     • Texas Moves Ahead Despite the Federal Ban ...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...

In this episode of TDR Cannabis in Five, host Shadd Dales covers one of the biggest federal cannabis documents ever released: the 252-page report from HHS, originally submitted to the DEA in August 2023. The report recommended moving cannabis from Schedule I to Schedule III — and laid out detailed scientific evidence showing medical use, lower abuse potential, and clear public-health benefits compared to strict prohibition.Shadd breaks down what the report actually found: clinical evidence supporting medical use, the FDA’s eight-factor analysis, the risks and benefits the government acknowledged, and the economic and regulatory consequences rescheduling would trigger. The discussion cuts through noise and focuses on what the federal government put in writing — not speculation.The episode also touches on how the report could shape research access, banking, tax rules, pharmaceutical engagement, and long-term investor confidence. While rescheduling isn’t legalization, the shift away from “no medical use” is a major narrative pivot.The conclusion stays grounded: the report doesn’t guarantee anything, and DEA still holds the final decision. But the detail, tone, and scientific backing make it a foundational moment in modern cannabis policy. It’s worth understanding for anyone who follows the sector seriously.#HHSReport #CannabisRescheduling #ScheduleIII #CannabisScience #TDRCannabisInFive #ShaddDales #CannabisPolicy #CannabisResearch #MorganAndMorgan #CannabisIndustryWant to see more Cannabis Reform videos?   • Three Months That Made Cannabis Impossible...     • Three Months That Made Cannabis Impossible...     • High Tide Executive Warns the Canadian Can...     • Texas Moves Ahead Despite the Federal Ban ...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:   / dalesreport  LinkedIn:   / the-dales-report  Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, please get in touch with us at:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered as endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions you make based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...